CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 434 entries

View as:

Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs

Phase: N/A Priority: Normal

NCT ID: NCT00634985 Org: User:

Start: 11/30/02 End: 12/31/03 Due: 12/31/04

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Phase: N/A Priority: Normal

NCT ID: NCT00537940 Org: User:

Start: 02/29/08 End: 07/31/13 Due: 07/31/14

Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo

Phase: N/A Priority: Normal

NCT ID: NCT01986270 Org: User:

Start: 12/31/96 End: 01/31/98 Due: 01/31/99

Study Of Celecoxib In Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00994461 Org: User:

Start: 11/30/09 End: 04/30/10 Due: 04/30/11

A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia

Phase: N/A Priority: Normal

NCT ID: NCT00645398 Org: User:

Start: 09/30/04 End: 06/30/05 Due: 06/30/06

Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

Phase: N/A Priority: Normal

NCT ID: NCT00407537 Org: User:

Start: 03/31/07 End: 10/31/09 Due: 10/31/10

A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis

Phase: N/A Priority: Normal

NCT ID: NCT00654017 Org: User:

Start: 10/31/02 End: 04/30/05 Due: 04/30/06

A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs

Phase: N/A Priority: Normal

NCT ID: NCT00649844 Org: User:

Start: 01/31/03 End: 09/30/04 Due: 09/30/05

A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.

Phase: N/A Priority: Normal

NCT ID: NCT00159913 Org: User:

Start: 08/31/03 End: 06/30/08 Due: 06/30/09

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

Phase: N/A Priority: Normal

NCT ID: NCT00239109 Org: User:

Start: 04/30/03 End: 02/28/07 Due: 02/28/08

Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.

Phase: N/A Priority: Normal

NCT ID: NCT00143208 Org: User:

Start: 05/31/03 End: 04/30/06 Due: 04/30/07

Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire

Phase: N/A Priority: Normal

NCT ID: NCT00147628 Org: User:

Start: 11/30/05 End: 09/30/06 Due: 09/30/07

A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.

Phase: N/A Priority: Normal

NCT ID: NCT00343200 Org: User:

Start: 07/31/06 End: 09/30/07 Due: 09/30/08

QEQ Treatment Responsiveness Evaluation Study

Phase: N/A Priority: Normal

NCT ID: NCT00151463 Org: User:

Start: 01/31/05 End: - Due: -

Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen

Phase: N/A Priority: Normal

NCT ID: NCT00638807 Org: User:

Start: 12/31/03 End: 07/31/04 Due: 07/31/05

A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.

Phase: N/A Priority: Normal

NCT ID: NCT00147589 Org: User:

Start: 09/30/04 End: 01/31/07 Due: 01/31/08

Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

Phase: N/A Priority: Normal

NCT ID: NCT01124877 Org: User:

Start: 07/31/10 End: 10/31/11 Due: 10/31/12

A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00866463 Org: User:

Start: 10/31/08 End: 10/31/08 Due: 10/31/09

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

Phase: N/A Priority: Normal

NCT ID: NCT00346216 Org: User:

Start: 10/04/06 End: 04/12/16 Due: 04/12/17

Pharmacokinetics and Relative Bioavailability Study

Phase: N/A Priority: Normal

NCT ID: NCT01521767 Org: User:

Start: 10/31/11 End: 11/30/11 Due: 11/30/12

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).

Phase: N/A Priority: Normal

NCT ID: NCT00383019 Org: User:

Start: 11/14/06 End: 10/01/07 Due: 10/01/08

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Phase: N/A Priority: Normal

NCT ID: NCT00139776 Org: User:

Start: 07/31/05 End: 02/29/08 Due: 02/28/09

A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00635531 Org: User:

Start: 04/30/04 End: 09/30/04 Due: 09/30/05

Efficacy and Tolerability of Xalatan in Patients

Phase: N/A Priority: Normal

NCT ID: NCT00950690 Org: User:

Start: 07/31/05 End: 12/31/07 Due: 12/31/08

Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)

Phase: N/A Priority: Normal

NCT ID: NCT01455428 Org: User:

Start: 12/31/11 End: 01/31/14 Due: 01/31/15

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs	NCT00634985	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2002-11-30	2003-12-31	2004-12-31	-	-	2025-07-14
Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures	NCT00537940	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-02-29	2013-07-31	2014-07-31	-	-	2025-07-14
Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo	NCT01986270	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	1996-12-31	1998-01-31	1999-01-31	-	-	2025-07-14
Study Of Celecoxib In Healthy Subjects	NCT00994461	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-11-30	2010-04-30	2011-04-30	-	-	2025-07-14
A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia	NCT00645398	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-09-30	2005-06-30	2006-06-30	-	-	2025-07-14
Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors	NCT00407537	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-03-31	2009-10-31	2010-10-31	-	-	2025-07-14
A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis	NCT00654017	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2002-10-31	2005-04-30	2006-04-30	-	-	2025-07-14
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs	NCT00649844	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-01-31	2004-09-30	2005-09-30	-	-	2025-07-14
A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.	NCT00159913	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-08-31	2008-06-30	2009-06-30	-	-	2025-07-14
Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.	NCT00239109	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-04-30	2007-02-28	2008-02-28	-	-	2025-07-14
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.	NCT00143208	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-05-31	2006-04-30	2007-04-30	-	-	2025-07-14
Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire	NCT00147628	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-11-30	2006-09-30	2007-09-30	-	-	2025-07-14
A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.	NCT00343200	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-07-31	2007-09-30	2008-09-30	-	-	2025-07-14
QEQ Treatment Responsiveness Evaluation Study	NCT00151463	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-01-31	-	-	-	-	2025-07-14
Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen	NCT00638807	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-12-31	2004-07-31	2005-07-31	-	-	2025-07-14
A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.	NCT00147589	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-09-30	2007-01-31	2008-01-31	-	-	2025-07-14
Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)	NCT01124877	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-07-31	2011-10-31	2012-10-31	-	-	2025-07-14
A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects	NCT00866463	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-10-31	2008-10-31	2009-10-31	-	-	2025-07-14
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen	NCT00346216	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-10-04	2016-04-12	2017-04-12	-	-	2025-07-14
Pharmacokinetics and Relative Bioavailability Study	NCT01521767	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-10-31	2011-11-30	2012-11-30	-	-	2025-07-14
A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).	NCT00383019	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-11-14	2007-10-01	2008-10-01	-	-	2025-07-14
Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"	NCT00139776	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-07-31	2008-02-29	2009-02-28	-	-	2025-07-14
A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder	NCT00635531	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-04-30	2004-09-30	2005-09-30	-	-	2025-07-14
Efficacy and Tolerability of Xalatan in Patients	NCT00950690	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-07-31	2007-12-31	2008-12-31	-	-	2025-07-14
Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)	NCT01455428	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-12-31	2014-01-31	2015-01-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance